A phase 2, double-blind, placebo-controlled trial of a valproate/lithium combination in ALS patients M.-C. Boll; M. Alcaraz-Zubeldia; C. Rios; D. González-Esquivel; S. Montes;

Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis A. Rivero-de-Aguilar; M. Mascareñas-García; M. Pérez-Ríos; M.A. Llaneza-Gonzalez; P. Mulero; M. Mendibe; À. Rovira; V. Meca-Lallana; A.J. García-Ruiz; L. Landete; J.R. Vizoso Hermida; P. Carrascal Rueda; A. Ruano-Raviña; M. Puente-Hernandez; L. Varela-Lema;

Design and validation of a questionnaire for monitoring neurological dysphagia and respiratory deterioration in patients with amyotrophic lateral sclerosis (DEREDELA) S. Bermudo Fuenmayor; P.J. Serrano Castro; P. Quiroga Subirana; S. López Palmero; M.M. Requena Mullor; T. Parrón Carreño;